ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION FOR PHARMACOINVASIVE OR PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Abstract

A primary percutaneous coronary intervention (P-PCI) still prefers the optimal reperfusion
therapy among patients with ST segment elevation myocardial infarction (STEMI), however,
in non-PCI capable hospitals, a pharmacoinvasive treatment (Ph-PCI) has can be done as
alternative therapy to P-PCI. This study compares the efficacy between a Ph-PCI and P-PCI
strategy among patients with STEMI